AURKA and non-small cell lung carcinoma: In contrast to the above reviewed studies, Lo lacono et al. [14] found that upregulated levels of AURKA in NSCLC biopsies as compared to corresponding normal lung tissues showed no correlation with patient survival and that the observed overexpression is restricted to specific subtypes and poorly differentiated lung cancers.